FDA faces important decisions on regulation of e-cigarettes
) Here are some rules of the road: Keep your comments civil. Don’t insult one another or the subjects of our articles. If you think a comment violates our guidelines click the “Report Abuse” link to notify the moderators. Responding to the comment will only encourage bad behavior. Don’t use profanities, vulgarities or hate speech. This is a general interest news site.
For the original version including any supplementary images or video, visit http://www.sacbee.com/2013/07/04/5544274/with-e-cigarettes-where-vapors.html
E-cigarette proponents say the product facilitates smoking fewer cigarettes and may help users quit entirely, but a longitudinal analysis using population-level data show no difference in quit rates among e-cigarette users and regular smokers. “Controlled clinical trials and population-level observational cohort studies are needed to establish the utility of these cigarettes to facilitate smoking cessation. Research is also needed regarding the role of e-cigarettes in harm reduction, including reduced cigarette smoking and associated reduction of tobacco toxicant exposure,” Benowitz and Goniewicz recommended.
For the original version including any supplementary images or video, visit http://www.clinicaladvisor.com/fda-faces-important-decisions-on-regulation-of-e-cigarettes/article/303113/